What is the event about?
51³Ô¹ÏÍø Collider returns, providing you the opportunity to meet world-leading researchers across 51³Ô¹ÏÍø’s health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker isÌýDr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
Ìý
What is the agenda?
- Full agenda available on
Ìý
What can you expect to take away from our event?
- Direct access to top voices in biomedical innovationÌýfrom 51³Ô¹ÏÍø, pharma, investment, and translational research.
- High-value networking opportunitiesÌýwith academics, founders, funders, and R&D leaders.
- Practical insight into the biomedical sector landscape, including key trends, partnerships, funding, and innovation pathways.
- Real examples of translational success, including topics likeÌýGLP biology, rhinovirus vaccines, antimicrobial resistance, precision medicine, and digital health.
- Strong emphasis on partnership-building, helping attendees identify collaborators and routes to commercial or clinical impact.
- Relevant for both early-career and senior attendees, whether they are seekingÌýfunding, industry links, research partners, or strategic insight.
Ìý
How will you benefit from our matchmaking experience?
PartneringONE is a powerful online platform that will enable speed meetings in advance.
- Targeted matchmakingÌýthrough a full day of curated 1:1 speed meetings.
- Efficient, high-value conversationsÌýwith each meeting lastingÌý25 minutes, ideal for focused introductions and opportunity scouting.
- Dedicated online partnering platformÌýfor a smooth and structured meeting experience.
- Advance profile browsingÌýso participants can identify the most relevant organisations and individuals before the event.
- Pre-scheduled tailored agendasÌýthat maximise time, relevance, and meeting outcomes.
- Streamlined networking experienceÌýcombining smart planning tools with productive live interactions.
Ìý
Who should attend?
-
51³Ô¹ÏÍø academics and researchers working in pharmaceuticals, drug discovery, healthcare and medtech
-
Early career researchers at 51³Ô¹ÏÍø are looking for industry partners or support in applying for grants and funding
-
Research and development leaders at medical companies are looking for an academic partner or inspiration on breakthrough areas of science
Ìý
What else do I need to know?
- Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
- This is a ticketed event with limited space. We reserve the right to cancel your ticket.
- There will be photography and filming at this event.
- For venue accessibility information, please contact Prashanthini (Prasshy) Jeyarajan: p.jeyarajan@imperial.ac.uk
- All guests registering for this event will be expected to adhere to 51³Ô¹ÏÍø’s Institutional Events code of conduct.
- Please return all digital/print lanyards, or a fine may be incurred.
For all other questions, please contact Prashanthini (Prasshy) Jeyarajan: p.jeyarajan@imperial.ac.uk
Who is sponsoring 51³Ô¹ÏÍø Collider: Health 2026?
HSBC Innovation Banking partners with high-growth venture-backed tech and life science businesses and their investors to build banking solutions that evolve as their ambitions, needs and footprint grow. Its Early-Stage Banking team offers pre-seed to Series A businesses startup expertise, ecosystem connections and scalable banking services to help them reach their Series A and beyond.